A new study published in the British Journal of Pharmacology has found that cannabis may treat neurodegenerative diseases such as Alzheimer’s disease.
“In an increasingly ageing population, the incidence of neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease and Huntington’s disease are rising”, according to the study. “While the aetiologies of these disorders are different, a number of common mechanisms that underlie their neurodegenerative components have been elucidated; namely neuroinflammation, excitotoxicity, mitochondrial dysfunction and reduced trophic support. Current therapies focus on treatment of the symptoms and attempt to delay the progression of these diseases but there is currently no cure.” It continues; “Modulation of the endogenous cannabinoid system is emerging as a potentially viable option in the treatment of neurodegeneration. Endocannabinoid signalling has been found to be altered in many neurodegenerative disorders.”
While studying the effects of cannabinoids in treating neurodegenerative diseases, it was found that; “Through multiple lines of evidence, this evolutionarily conserved neurosignalling system has shown neuroprotective capabilities and is therefore a potential target for neurodegenerative disorders.”They conclude; “This review details the mechanisms of neurodegeneration and highlights the beneficial effects of cannabinoid treatment.”
The full study can be found by clicking here.